Zobrazeno 1 - 10
of 160
pro vyhledávání: '"antiresorptive agent"'
Autor:
Maximilian Gottsauner, Johannes Meier, Jonas Eichberger, Stephanie Eckmüller, Johannes Schuderer, Mathias Fiedler, Michael Maurer, Torsten E. Reichert, Tobias Ettl
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundThe aim of this study was to investigate the effect of antiresorptive agents on the ossification of reconstructed mandibles by free bone grafts for the first time.MethodsA total of 38 reconstructions of the jaw were retrospectively evaluate
Externí odkaz:
https://doaj.org/article/26d7848e6bcc42a88cafef39fde8db2f
Autor:
Taro Okui, Yoshikazu Kobayashi, Madoka Isomura, Masakazu Tsujimoto, Koji Satoh, Hiroshi Toyama
Publikováno v:
Fujita Medical Journal, Vol 9, Iss 3, Pp 186-193 (2023)
Objectives: This study investigated the relationships between quantitative values calculated from bone single photon emission computed tomography/computed tomography (SPECT/CT) images and histopathological findings observed in surgical specimens from
Externí odkaz:
https://doaj.org/article/cfb44dc1ad8c4525bfdb621fcda50c14
Autor:
Masanori Nashi, Hiromitsu Kishimoto, Masaki Kobayashi, Akira Tachibana, Motoo Suematsu, Shigeyoshi Fujiwara, Yoshiyuki Ota, Susumu Hashitani, Takeshi Shibatsuji, Tetsuya Nishida, Kazuma Fujimura, Shungo Furudoi, Yoshiki Ishida, Shoichiro Ishii, Tsuyoshi Fujita, Soichi Iwai, Takashi Shigeta, Takeshi Harada, Daisuke Miyai, Daisuke Takeda, Masaya Akashi, Kazuma Noguchi, Toshihiko Takenobu
Publikováno v:
Journal of Dental Sciences, Vol 18, Iss 3, Pp 1156-1163 (2023)
Background/purpose: The incidence of medication-related osteonecrosis of the jaw is increasing worldwide, mostly due to the use of antiresorptive agents (ARAs) such as bisphosphonate (BP) and denosumab (Dmab). However, the proportion of BP-related os
Externí odkaz:
https://doaj.org/article/42efd85597f74d9aa54eee2b073ce54a
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Osteoporosis (OP) is known as a silent disease in which the loss of bone mass and bone density does not cause obvious symptoms, resulting in insufficient treatment and preventive measures. The losses of bone mass and bone density become more severe o
Externí odkaz:
https://doaj.org/article/40c0742f67344c849d8b7bec747cb99d
Publikováno v:
Clinical Case Reports, Vol 8, Iss 12, Pp 2925-2934 (2020)
Abstract Intraoral localized methotrexate‐associated lymphoproliferative disorders can cause antiresorptive agent‐related osteonecrosis of the jaw associated with infection due to its immunological abnormalities and ulcer formation.
Externí odkaz:
https://doaj.org/article/540c88bce5494218b2dedecd32aae3e0
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 10 (2022)
Despite medication-related osteonecrosis of the jaw (MRONJ) being first reported in 2003, the optimal treatment and prevention modalities for MRONJ are not clear. As a result, dentistry, oral surgery, and departments involved in the treatment of canc
Externí odkaz:
https://doaj.org/article/a5fabde298ab458ab9f33a424f3bcab3
Autor:
ITO, Kana, IIJIMA, Heisuke, KUMAGAI, Masatoshi, YABUSAKI, Ryo, MURO, Yusuke, SHIRAISHI, Yusuke, IMAMURA, Masaaki, YOSHIMURA, Koji
Publikováno v:
泌尿器科紀要. 69(5):125-129
Antiresorptive agent-related osteonecrosis of the jaw (ARONJ) is a severe adverse event associated with use of bone resorption inhibitors (BRIs), such as zoledronic acid and denosumab. Based on the results of phase 3 clinical trials for BRIs, the fre
Autor:
Cristina Mirelli, Sonia Marino, Andrea Bovio, Sara Pederielli, Cristina Dall’Agnola, Aldo Bruno Gianni, Roberto Biagi
Publikováno v:
Dentistry Journal, Vol 10, Iss 5, p 89 (2022)
A retrospective analysis was performed with the aim of understanding whether the risk factors showed in the literature for medication-related osteonecrosis of the jaws (MRONJ) in cancer patients are also relevant in osteoporotic patients taking antir
Externí odkaz:
https://doaj.org/article/58955ce7eee04f4d8cfe64638afb2c26
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.